An appraisal of the food and drug administration warning on urogynecologic surgical mesh

Current Urology Reports

Volumn 13, Issue 3, 2012, Pages 231-239

  Menchen, Lindsey C ^a   Wein, Alan J ^a   Smith, Ariana L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Complication; Pelvic organ prolapse; Reconstructive surgery pelvic floor; Surgical mesh

Indexed keywords

BLEEDING; DEVICE SAFETY; DISEASE ASSOCIATION; DYSPAREUNIA; FOOD AND DRUG ADMINISTRATION; HEMATOMA; HUMAN; IATROGENIC DISEASE; OUTCOME ASSESSMENT; PATIENT SAFETY; PATIENT SATISFACTION; PELVIC ORGAN PROLAPSE; PELVIS PAIN SYNDROME; PELVIS SURGERY; PRACTICE GUIDELINE; QUALITY OF LIFE; REVIEW; SEXUAL BEHAVIOR; SEXUAL FUNCTION; STOMACH EROSION; SURGICAL EQUIPMENT; SURGICAL INFECTION; TREATMENT FAILURE; TREATMENT RESPONSE; URINARY DYSFUNCTION;

CYSTOSCOPY; EQUIPMENT SAFETY; HUMANS; PATIENT SELECTION; PELVIC FLOOR; PRODUCT SURVEILLANCE, POSTMARKETING; RECONSTRUCTIVE SURGICAL PROCEDURES; SURGICAL MESH; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84864841399     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-012-0244-2     Document Type: Review

References (24)

1. Food and Drug Administration. Urogynecologic surgical mesh: update on the safety and effectiveness of transvaginal placement for pelvic organ prolapse. http://www.fda.gov/downloads/MedicalDevices/Safety/AlertsandNotices/UCM262760. pdf (2011). Accessed 2 January 2012.
2. Haylen BT, Freeman RM, Swift SE, Cosson M, Davila GW, Deprest J, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint terminology and classification of the complications related directly to the insertion of prostheses (meshes, implants, tapes) and grafts in female pelvic floor surgery. Neurourol Urodyn. 2011;30:2-12.
3. Food and Drug Administration. FDA public health notification: serious complications associated with transvaginal placement of surgical mesh in repair of pelvic organ prolapse and stress urinary incontinence. http://www.fda.gov/ MedicalDevices/Safety/Alertsand Notices/PublicHealthNotifications/ucm061976.htm (2008). Accessed 2 January 2012.
4. Goldman H, FitzGerald MP. Opposing views transvaginal mesh for cystocele repair. J Urol. 2010;183:430-2.
5. van Raalte H, Lucente V, Molden S, Haff R, Murphy M. One-year anatomic and quality-of-life outcomes after the prolift procedure for treatment of posthysterectomy prolapse. Am J Obstet Gynecol. 2008;199:694.e1-6.
6. Chen CCG, Ridgeway B, Paraiso MFR. Biologic grafts and synthetic meshes in pelvic reconstructive surgery. Clin Obstet Gynecol. 2007;50:383-411.
7. Young S, Schaffer J, Lucero M. Society of gynecologic surgeons' survey: mesh use in vaginal prolapse surgery. Female Pelvic Med Reconstr Surg. 2010;16:336-9.
8. Freeman RM, Lose G The great mesh debate. Int Urogynecol J. 2009;20:889-91.
9. Jia X, Glazener C, Mowatt G, Jenkinson D, Fraser C, Bain C, et al. Systematic review of the efficacy and safety of using mesh in surgery for uterine or vaginal vault prolapse. Int Urogynecol J. 2010;21:1413-31.
10. Gomelsky A, Penson DF, Dmochowski RR. Pelvic Organ Prolapse (POP) surgery: the evidence for the repairs. Br J Urol. 2011;107:1704-19.
11. Altman D, Väyrynen T, Engh ME, Axelsen S, Falconer C. Anterior colporrhaphy versus transvaginal mesh for pelvic-organ prolapse. N Engl J Med. 2011;364:1826-36.
12. Jacquetin B, Cosson M. Complications of vaginal mesh: our experience. Int Urogynecol J. 2009;20:893-6.
13. Food and Drug Administration. FDA perspective on surgical mesh for Pelvic Organ Prolapse (POP) FDA Overview-POP. http://www.fda. gov/downloads/ AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/ MedicalDevicesAdvisoryCommittee/ObstetricsandGynecologyDevices/UCM271283.pdf (2011). Accessed 2 January 2012.
14. Abed H, Rahn DD, Lowenstein L, Balk EM, Clemons JL, Rogers RG. Incidence and management of graft erosion, wound granulation, and dyspareunia following vaginal prolapse repair with graft materials: a systematic review. Int Urogynecol J. 2011;22: 789-98.
15. American Urogynecologic Society. American Urogynecologic Society (AUGS) response: FDA safety communication: UPDATE on serious complications associated with transvaginal placement of surgical mesh for pelvic organ prolapse. http://www.augs.org/p/cm/ld/fid0163 (2011). Accessed 31 December 2011.
16. National Association for Continence. NAFC's position statement for vaginal mesh for pelvic surgery. http://www.nafc.org/about/advocacy-efforts/ nafc-s-position-statement-for-vaginal-mesh (2011). Accessed 31 December 2011.
17. Society for Urodynamics and Female Urology. Society for Urody-namics and Female Urology (SUFU) response: FDA safety communication: UPDATE on serious complications associated with transvaginal placement of surgical mesh for pelvic organ prolapse (July 2011). http://www.sufuorg.com/pdf/SUFU%20FDA%20 response%207%2018%2011.pdf (2011). Accessed 31 December 2011.
18. American Urological Association (Board of Directors). AUA position statement on the use of vaginal mesh for the repair of pelvic organ prolapse. http://www.auanet.org/content/aua-policies/position-statements/ pelvic-organ-prolapse.cfm (2011). Accessed 31 December 2012.
19. Ridgeway B, Walters MD, Paraiso MFR, Barber MD, McAchran SE, Goldman HB, et al. Early experience with mesh excision for adverse outcomes after transvaginal mesh placement using prolapse kits. Am J Obstet Gynecol. 2008;199:703-e1.
20. Lee U. Emerging concepts for pelvic organ prolapse surgery: what is cure? Curr Urol Rep. 2011;12:62-7.
21. Culligan PJ, Littman PM, Salamon CG, Priestley JL, Shariati A. Evaluation of a transvaginal mesh delivery system for the correction of pelvic organ prolapse: subjective and objective findings at least 1 year after surgery. Am J Obstet Gynecol. 2010;203:506.e1-6.
22. Dietz HP, Erdmann M, Shek KL. Mesh contraction: myth or reality? Am J Obstet Gynecol. 2011;204:173-e1.
23. Aboushwareb T, Mckenzie P, Wezel F, Southgate J, Badlani G, Salem W, et al. Is tissue engineering and biomaterials the future for Lower Urinary Tract Dysfunction (LUTD)/Pelvic Organ Prolapse (POP)? Neurourol Urodyn. 2011;782:775-82.
24. Mucowski SJ, Jurnalov C, Phelps JY. Use of vaginal mesh in the face of recent FDA warnings and litigation. Am J Obstet Gynecol. 2010;203:103.e1-4.